GBI Research

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research i
nclude:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.
GBI Research
 

List of reports from GBI Research

2  3  4  5    7    9  10  11  
Biobanks - 2012 Year Book
7/10/2012 | published by: GBI Research
... major biobanks. The report provides information on population-based biobanks, disease based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and many national biobanks. It also provides comprehensive analysis of funding, harmonization, the cost ...  |  read more...
USD 3,500
Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth
7/10/2012 | published by: GBI Research
... “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth” that provides key data, information and analysis of the major trends and issues ...  |  read more...
USD 3,500
Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing
7/1/2012 | published by: GBI Research
... MNCs to Partner with Local Players Resulting in Profit and Control Sharing” provides an in-depth analysis of the trends, issues and challenges in the pharmaceutical market in Brazil. The report analyzes the overall pharmaceutical and ...  |  read more...
USD 3,500
Wound Care Management Market to 2018 - Advanced Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries
6/30/2012 | published by: GBI Research
... Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries” provides key data, information and analysis on the global wound care management market. The report provides a market landscape, competitive ...  |  read more...
USD 3,500
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards
6/25/2012 | published by: GBI Research
... Failures, Close Regulatory Surveillance and High Compliance Standards”, provides in-depth analysis of the unmet needs, drivers and barriers that impact the global gene therapy market. The report analyzes technological aspects, advantages and disadvantages of various ...  |  read more...
USD 3,500
Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
6/25/2012 | published by: GBI Research
... US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits”. It analyzes the overall Supply Chain Management (SCM) scenario and provides profiles of the leading participants in the pharmaceutical supply chain in the ...  |  read more...
USD 3,500
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
6/25/2012 | published by: GBI Research
... Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles” presents the use of endpoints or outcomes measures in respiratory disease’s clinical trials. In this report, endpoint used in asthma, cystic fibrosis, ...  |  read more...
USD 3,500
Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue
6/25/2012 | published by: GBI Research
... the Market with More Than 55% of the Industry Revenue” provides in-depth analysis of trends, issues and challenges in the pharmaceutical market in Argentina. The report analyzes the overall pharma and clinical trials market in ...  |  read more...
USD 3,500
Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth
6/25/2012 | published by: GBI Research
... Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth” describes generic market in antiviral therapeutics. This report covers antiviral therapeutics including HIV therapeutics, Hepatitis ...  |  read more...
USD 3,500
Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
6/25/2012 | published by: GBI Research
... latest report, “Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production” that provides key data, information and analysis of the ...  |  read more...
USD 3,500
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications
6/12/2012 | published by: GBI Research
... CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications”, which provides insights into the global regenerative medicine therapeutics market. The report provides an in-depth analysis of regenerative medicine and the challenges in ...  |  read more...
USD 3,500
Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth
6/12/2012 | published by: GBI Research
... Countries Will Underpin Future Pharma Growth” which examines two major trends already impacting on marketing strategies in the global pharmaceutical environment. These trends are the rise in importance of biologic products as replacements for the ...  |  read more...
USD 3,500
Negative Pressure Wound Therapy Market to 2017 - Recent Approvals in Japan and Large Diabetes Patient Pool in Emerging Countries to Present Opportunities for Growth
6/12/2012 | published by: GBI Research
... 2017 - Recent Approvals in Japan and Large Diabetes Patient Pool in Emerging Countries to Present Opportunities for Growth” provides key data, information and analysis on the global negative pressure wound therapy market. The report ...  |  read more...
USD 3,500
Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar
6/12/2012 | published by: GBI Research
... has released its latest research, “Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar”, which provides insights ...  |  read more...
USD 3,500
Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures
6/12/2012 | published by: GBI Research
... in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures”. The report provides a comprehensive overview of the healthcare system, and pricing and reimbursement process in China with key data, information ...  |  read more...
USD 3,500
Emerging Pharmaceutical Market in South Africa to 2017 - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process
6/12/2012 | published by: GBI Research
... - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process” provides in-depth analysis of the trends, issues and challenges in South Africa’s pharmaceutical market. The report analyzes the overall pharmaceutical and ...  |  read more...
USD 3,500
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward
6/12/2012 | published by: GBI Research
... Innovation and Collaboration Will Drive the Industry Forward”. Job losses within the pharmaceutical industry are an on-going reality. In the light of this fact, this new report focuses on managing staff during the redundancy process ...  |  read more...
USD 3,500
Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision Making
6/12/2012 | published by: GBI Research
... and Orphan Drugs to Shape Future Decision Making”, which examines the key issues influencing the re-evaluation of pharmaceutical pipelines due to changes in the economic environment, the emergence of new markets, M&A and partnering activity, ...  |  read more...
USD 3,500
Emerging Pharmaceutical Market in Indonesia and Philippines - 100% Foreign Direct Investment in Indonesia and Extensive Insurance Coverage in the Philippines Attract Foreign Pharma Companies
6/4/2012 | published by: GBI Research
... and Philippines - 100% Foreign Direct Investment in Indonesia and Extensive Insurance Coverage in the Philippines Attract Foreign Pharma Companies”, provides an in-depth analysis of trends, issues and challenges in the pharmaceutical market in Indonesia ...  |  read more...
USD 3,500
Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
5/18/2012 | published by: GBI Research
... Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications”, provides an expert insight into the global arthritis market and market forecast until 2018. The report is ...  |  read more...
USD 3,500
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge
5/18/2012 | published by: GBI Research
... Drive Drug Development, but Improving Patient Involvement Remains a Challenge”. The report examines the role of patients in changing the research agenda and helping pharma companies to bring effective medicines that meet real unmet medical ...  |  read more...
USD 3,500
Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs
5/18/2012 | published by: GBI Research
... Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs”. It provides a comprehensive overview of the healthcare system, and pricing and reimbursement process in Brazil with ...  |  read more...
USD 3,500
Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs
5/18/2012 | published by: GBI Research
... released its latest research “Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs”. It provides a comprehensive overview ...  |  read more...
USD 3,500
Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
5/18/2012 | published by: GBI Research
... Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential”, which provides key data, information and analysis for the global antibacterials market (covering tuberculosis, pneumonia, urinary tract infections, atypical bronchitis, tonsillitis, sinusitis and otitis media ...  |  read more...
USD 3,500
Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management
5/18/2012 | published by: GBI Research
... - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management”, provides in-depth analysis of unmet needs, drivers and barriers that impact the opioids market. The report analyzes current method of practice ...  |  read more...
USD 3,500
2  3  4  5    7    9  10  11  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!